search
Back to results

Effectiveness of KneeMD on Flexion Contracture in Total Knee Arthroplasty Patients (KneeMD)

Primary Purpose

Flexion Contracture

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
KneeMD
Sponsored by
Anne Arundel Health System Research Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Flexion Contracture

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Measurable Knee Flexion Contracture, with deficit limiting Active Range of Motion (AROM) and Passive Range of Motion (PROM) by at least - 10°
  2. 18 years of age and older
  3. Able to understand informed consent and willingness to conform to trial responsibilities

Exclusion Criteria:

  1. Previous surgical treatment of knee, including tibial osteotomy
  2. Botulinum Toxin Treatment within the last four months
  3. Mechanical joint impingement
  4. Neuromuscular pathologies such as epilepsy
  5. Treatment with quinolone, antibiotic medication
  6. Pregnant or nursing
  7. Fractures
  8. Osteomyelitis or any orthopedic infection
  9. Extensor mechanism dysfunction
  10. Knee joint neuropathy
  11. Previous Stroke or Brain Injury

Sites / Locations

  • Anne Arundel Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control

Experimental

Arm Description

The control subjects will be treated with only the current SOC including NSAIDs and physical therapy.

The experimental subjects will be treated with current SOC and will also use a kneeMD splint 3 times a day for 20 minutes per session

Outcomes

Primary Outcome Measures

AROM
Change in maximal active range of motion in

Secondary Outcome Measures

AROM
Active Range of motion in degrees

Full Information

First Posted
December 18, 2015
Last Updated
February 6, 2019
Sponsor
Anne Arundel Health System Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT02638480
Brief Title
Effectiveness of KneeMD on Flexion Contracture in Total Knee Arthroplasty Patients
Acronym
KneeMD
Official Title
A Prospective Randomized Trial to Examine the Effectiveness of KneeMD on Flexion Contracture in Total Knee Arthroplasty Patients
Study Type
Interventional

2. Study Status

Record Verification Date
February 2019
Overall Recruitment Status
Unknown status
Study Start Date
November 2015 (undefined)
Primary Completion Date
March 2019 (Anticipated)
Study Completion Date
April 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Anne Arundel Health System Research Institute

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to evaluate the effect of the KneeMD subject-controlled knee rehabilitation device on the incidence of postoperative flexion contracture.
Detailed Description
Postoperative flexion contracture (FC), defined as >10°, is the most common disabling early complication of primary total knee replacement (TKR) surgery, affecting up to 6% of all subjects. A knee flexion of 65° is required to walk, 70° is needed to lift an object from the floor, 85° to climb stairs, 95° for optimal sitting and standing, and 105° to tie shoelaces. With growing subject and physician expectations for function and range of motion (ROM) after surgery, FC complications have become an early measure of success in TKR surgery. The purpose of this study is to evaluate the effect of the KneeMD subject-controlled knee rehabilitation device on the incidence of postoperative FC. The primary endpoints are the preoperative change in active range of motion (AROM) and the incidence of postoperative FC at 2 weeks. Secondary endpoints include the change in AROM in subjects with postoperative FC.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Flexion Contracture

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
The control subjects will be treated with only the current SOC including NSAIDs and physical therapy.
Arm Title
Experimental
Arm Type
Experimental
Arm Description
The experimental subjects will be treated with current SOC and will also use a kneeMD splint 3 times a day for 20 minutes per session
Intervention Type
Device
Intervention Name(s)
KneeMD
Intervention Description
KneeMD is a subject-controlled knee rehabilita¬tion device that helps subjects who have undergone total knee replacements or other major knee surger¬ies improve range of motion and stretch in extension.
Primary Outcome Measure Information:
Title
AROM
Description
Change in maximal active range of motion in
Time Frame
4 weeks after randomization
Secondary Outcome Measure Information:
Title
AROM
Description
Active Range of motion in degrees
Time Frame
2 weeks postoperatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Measurable Knee Flexion Contracture, with deficit limiting Active Range of Motion (AROM) and Passive Range of Motion (PROM) by at least - 10° 18 years of age and older Able to understand informed consent and willingness to conform to trial responsibilities Exclusion Criteria: Previous surgical treatment of knee, including tibial osteotomy Botulinum Toxin Treatment within the last four months Mechanical joint impingement Neuromuscular pathologies such as epilepsy Treatment with quinolone, antibiotic medication Pregnant or nursing Fractures Osteomyelitis or any orthopedic infection Extensor mechanism dysfunction Knee joint neuropathy Previous Stroke or Brain Injury
Facility Information:
Facility Name
Anne Arundel Medical Center
City
Annapolis
State/Province
Maryland
ZIP/Postal Code
21401
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
18751792
Citation
Gonzalez Della Valle A, Leali A, Haas S. Etiology and surgical interventions for stiff total knee replacements. HSS J. 2007 Sep;3(2):182-9. doi: 10.1007/s11420-007-9053-4.
Results Reference
background
PubMed Identifier
17029180
Citation
Pariente GM, Lombardi AV Jr, Berend KR, Mallory TH, Adams JB. Manipulation with prolonged epidural analgesia for treatment of TKA complicated by arthrofibrosis. Surg Technol Int. 2006;15:221-4.
Results Reference
background
PubMed Identifier
16490357
Citation
Yercan HS, Sugun TS, Bussiere C, Ait Si Selmi T, Davies A, Neyret P. Stiffness after total knee arthroplasty: prevalence, management and outcomes. Knee. 2006 Mar;13(2):111-7. doi: 10.1016/j.knee.2005.10.001. Epub 2006 Feb 20.
Results Reference
background
PubMed Identifier
5061683
Citation
Laubenthal KN, Smidt GL, Kettelkamp DB. A quantitative analysis of knee motion during activities of daily living. Phys Ther. 1972 Jan;52(1):34-43. doi: 10.1093/ptj/52.1.34. No abstract available.
Results Reference
background
PubMed Identifier
4030819
Citation
Schurman DJ, Parker JN, Ornstein D. Total condylar knee replacement. A study of factors influencing range of motion as late as two years after arthroplasty. J Bone Joint Surg Am. 1985 Sep;67(7):1006-14.
Results Reference
background
PubMed Identifier
20541887
Citation
Mitsuyasu H, Matsuda S, Miura H, Okazaki K, Fukagawa S, Iwamoto Y. Flexion contracture persists if the contracture is more than 15 degrees at 3 months after total knee arthroplasty. J Arthroplasty. 2011 Jun;26(4):639-43. doi: 10.1016/j.arth.2010.04.023. Epub 2010 Jun 11.
Results Reference
background
PubMed Identifier
18078875
Citation
Ritter MA, Lutgring JD, Davis KE, Berend ME, Pierson JL, Meneghini RM. The role of flexion contracture on outcomes in primary total knee arthroplasty. J Arthroplasty. 2007 Dec;22(8):1092-6. doi: 10.1016/j.arth.2006.11.009.
Results Reference
background
PubMed Identifier
22146201
Citation
Goudie ST, Deakin AH, Ahmad A, Maheshwari R, Picard F. Flexion contracture following primary total knee arthroplasty: risk factors and outcomes. Orthopedics. 2011 Dec 6;34(12):e855-9. doi: 10.3928/01477447-20111021-18.
Results Reference
background
PubMed Identifier
15972905
Citation
Aderinto J, Brenkel IJ, Chan P. Natural history of fixed flexion deformity following total knee replacement: a prospective five-year study. J Bone Joint Surg Br. 2005 Jul;87(7):934-6. doi: 10.1302/0301-620X.87B7.15586.
Results Reference
background
PubMed Identifier
12788004
Citation
Lam LO, Swift S, Shakespeare D. Fixed flexion deformity and flexion after knee arthroplasty. What happens in the first 12 months after surgery and can a poor outcome be predicted? Knee. 2003 Jun;10(2):181-5. doi: 10.1016/s0968-0160(02)00102-3.
Results Reference
background
PubMed Identifier
23142447
Citation
Koh IJ, Chang CB, Kang YG, Seong SC, Kim TK. Incidence, predictors, and effects of residual flexion contracture on clinical outcomes of total knee arthroplasty. J Arthroplasty. 2013 Apr;28(4):585-90. doi: 10.1016/j.arth.2012.07.014. Epub 2012 Nov 8.
Results Reference
background

Learn more about this trial

Effectiveness of KneeMD on Flexion Contracture in Total Knee Arthroplasty Patients

We'll reach out to this number within 24 hrs